Company Description

Mangoceuticals, Inc. develops, markets, and sells various men's wellness products and services through a telemedicine platform in the United States.

It offers erectile dysfunction (ED) products under the Mango brand and hair loss products under the Grow brand name.

The company markets and sells these branded ED and hair loss products online through its website at MangoRx.com.

Mangoceuticals, Inc. has a marketing agreement with Marius Pharmaceuticals, LLC to market and sell KYZATREX, an oral testosterone replacement therapy product under the PRIME program.

The company was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. is a subsidiary of Cohen Enterprises, Inc.

Mangoceuticals, Inc.

Country	United States
Founded	2021
IPO Date	Mar 21, 2023
Industry	Health Information Services
Sector	Healthcare
Employees	3
CEO	Jacob D. Cohen

Contact Details

Address: 15110 Dallas Pkwy, Suite 600 Dallas, Texas 75248 United States
Phone	(833) 626-4679
Website	mangorx.com

Stock Details

Ticker Symbol	MGRX
Exchange	NASDAQ
Fiscal Year	January - December
Reporting Currency	USD
IPO Price	$4.00
CIK Code	0001938046
CUSIP Number	56270V106
ISIN Number	US56270V1061
Employer ID	87-3841292
SIC Code	8090

Key Executives

Name	Position
Jacob D. Cohen	Chief Executive Officer and Chairman
Eugene M. Johnston	Chief Financial Officer
Amanda Elizabeth Hammer	Chief Operating Officer

Latest SEC Filings

Date	Type	Title
Jul 2, 2024	8-K	Current Report
Jun 24, 2024	144/A	Filing
Jun 20, 2024	144/A	Filing
Jun 18, 2024	144	Filing
Jun 18, 2024	8-K	Current Report
Jun 10, 2024	144	Filing
Jun 5, 2024	8-K	Current Report
Jun 5, 2024	SC 13D/A	[Amend] General statement of acquisition of beneficial ownership
May 16, 2024	ARS	Filing
May 16, 2024	DEF 14A	Other definitive proxy statements

View All SEC Filings